Kidney transplantation remains the optimal treatment for patients with end-stage kidney disease, offering superior survival, quality of life, and cost-effectiveness compared with dialysis. Yet the persistent and widening gap between organ supply and demand continues to limit timely access to transplantation.
As a result, many patients remain dependent on long-term dialysis, often with substantial morbidity and mortality. Xenotransplantation has long been envisioned as a potential solution to this shortage by enabling a more predictable and scalable source of transplantable organs.
Kidney International published a clinical update in Research Highlights on 06 Apr 2026.
The item focuses on Kidney xenotransplantation at a clinical inflection point.
Review the original article for the full source wording and details.